This move is archived. Current quotes and coverage live on the stock page.
Get APTX alerts:
Apotex Health Corp is seeing a significant rise in its stock price today, reflecting positive sentiment from investors.
In the latest trading session, Apotex Health Corp (APTX.TO) saw its stock increase by 4.45%, closing at CA$32.40. This uptick comes as interest in the pharmaceutical sector grows, particularly with the company preparing for its upcoming IPO.
Advertisement
Apotex Health Corp
APTX.TO
APTX.TO
Apotex Health Corp
WealthAwesomeMarket cap
$7.57B
52W high
$40.18
52W low
$26.05
1W change
-1.33%
Analyst Price Targets
Based on analyst covering APTX
Wall Street analysts forecast APTX stock price to rise 26.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$41.34
+26.7% Upside
Current Price
C$32.62
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APTX's historical volatility
30-Day Vol
37.1%
Annualized
90-Day Vol
47.8%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$39.00
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$34.62 | C$30.46 – C$39.35 |
| 60 trading days | C$36.74 | C$30.66 – C$44.04 |
| 90 trading days | C$39.00 | C$31.24 – C$48.68 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors are reacting positively to Apotex's strategic initiatives, especially its recent IPO activities, which may indicate strong growth potential ahead.
Apotex Health Corp Market Cap Reaches CA$7.39 Billion
With a market cap of CA$7.39 billion and a P/E ratio of 19.86, Apotex is set for growth, but investors should keep an eye on its profit margins.
Bull case
The excitement around Apotex's IPO and the recent approval of its ophthalmic product, IHEEZO™, is boosting investor confidence. This could lead to a larger market share and increased profitability in the upcoming quarters.
Bear case
Despite the positive trends, investors should stay cautious about potential market volatility and the risks that come with new IPOs in the pharmaceutical sector.
Recent Performance
Advertisement
In the last trading session, Apotex Health Corp's stock price rose by 4.45%, showing strong investor interest. The closing price of CA$32.40 marks a notable gain as the company prepares for its IPO, which is expected to attract significant attention.
Strategic Moves
Apotex is currently in the spotlight due to its upcoming IPO, which could secure substantial capital for expansion. Additionally, the recent approval of IHEEZO™ by Health Canada enhances the company's growth narrative, potentially expanding its product portfolio and market presence.
Investor Considerations
While the current outlook appears promising, investors should take into account broader market conditions and the risks associated with IPOs. Keeping track of Apotex's financial health and product performance will be vital for assessing its long-term viability.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
